Colombian Companies to begin export of cannabis to Canadian companies

Clever Leaves is a licensed Columbian producer of pharmaceutical-grade medical marijuana. It is the first company to get permission for exporting cannabis to Canada. This vertically-integrated company has attained a high-level success as Colombia has recently announced the legalization of medical cannabis.
On similar notes, Khiron Life Sciences Corporation has announced a partnership with US-based company Dixie which is another move to authorize cannabis export. Khiron Life Sciences is a Colombia-based company serving urgent-care requirements.
PharmaCielo, a Colombian cannabis company has attained an export license for medical marijuana oils. The beginning of its commercial sales has given a positive move to the company and it is looking forward to attaining great results with the advantage of legalized cannabis.
The government agency responsible for national public health of medical industry has permitted Clever Leaves for importing the dry cannabis flower from Colombia to Canada for testing purposes. This is by far the first time any Colombian company has been permitted to grow legal cannabis for some other nation. Clever Leaves fulfills all the requirements given by Health Canada for obtaining permission for import.
The Colombian government has regulated the use of cannabis only for medicinal usage. The cultivation has been done in a fair way to pass the inspection and get ahead with the positive notes for the company. At present, the Colombian government allows the export of cannabis oil only and dry cannabis flower is not permissible. Clever Leaves has always tried to accomplish the credibility of the company inch-by-inch to compete with the PharmaCielo Colombia Holdings. The company’s aim for commercial sales have almost begun and seems to pass all the standards.
Even if the dry-flower sales are not feasible, it is a major step for ensuring that the product is in compliance with the international medical cannabis standards and meets the quality in terms of every important aspect. The test results of the products being exported will determine the scope of the company to ship medical cannabis oil to the Canadian licensed operators in the future. Clever Leaves will subsequently begin the sale of CBD products in Europe and high-THC medical products in the German market. Clever Leaves was founded in 2017 and within 2 years of their operation, they claim to have strong business ethics and the working team of 200+ employees.
The company PharmaCielo has presented the facility of 12.1 hectares of cannabis greenhouses ready for cultivation. The seedlings are planted to contract growers and their own land to produce high-quality cannabis for medical usage. The company has even announced that it has got the approval of National Cultivar Registry for listing 10 unique CBD and THC strains. The business can proceed for commercial registration, manufacturing, and sale of strains to be used by Colombian companies and even exported to the worldwide markets.
Colombian companies can really succeed if they follow the dedicated and ethical approach to produce high-quality cannabis for spiritual and medicinal usage. Many countries are heading towards legalization of cannabis and it is quite sure that the market will bloom with the growing trends and research for cannabis.

Colombia’s approval for Medical Cannabis

Marijuana has been used for thousands of years. The major purpose of this drug for the people was to get high and it is majorly possible due to the primary ingredient THC (TetraHydroCannabinol). There are many medicinal purposes for which this drug is being used and it possesses some therapeutic properties if taken in right form, amount and timing. There are people who still use this drug for getting high and this is the recreational use of cannabis. However, taking an account of the medical uses, there are many countries which have permitted cannabis usage for various segments. Colombia is one of the recent nations which has allowed medical use of cannabis.

Medical cannabis is presently allowed in 31 countries in the world. Despite terming it as ‘illegal’, there are many states which have decriminalized personal usage of marijuana. The different between legalization and decriminalization is that legalization permits the use of marijuana without any legal complications or bounds whereas, decriminalization means the relaxation of the criminal penalties for violating the laws related to marijuana.

The Food and Drug Administration had already given approval for synthetic cannabinoids (Nabilone and Dronabinol) for treating vomiting and nausea associated with cancer chemotherapy. The US Food and Drug Administration has given approval to 3 cannabinoids. In the recent phases, GW Pharmaceuticals has attained success in treating two forms of epilepsy by getting FDA approval for the drug Epidiolex. The legalization of recreational marijuana is not much prevalent but many states are under the process to pass this on.

There are 3 major types of stocks included for medical or recreational marijuana sector:
Marijuana growers: Cultivation and plantation of cannabis plants in indoor facilities or greenhouses, harvesting the crops and finally, selling it to the customers
Cannabis-focusing biotech companies: These companies perform research and development for developing drugs including cannabinoids.

Service providers: There are service providers associated with every industry and cannabis sector is no different. It includes the various levels of providers linked at every stage to establish a smooth supply of cannabis throughout the region and even on the export platform.

Marijuana stocks were volatile in 2018 with the unsure decision by the government for legalization matters. The stocks were highly speculative and the new companies with great ideas were even seen with a dilemmatic eye. The administration of Trump has given a green-signal to many companies to initiate their business with the altered business-models and the legalized approach towards investments.

The markets suffered a lot with the ongoing sluggish decisions made by the governments. Colombia’s decision for permitting medical usage of cannabis has given a new start to the wide range of countries to initiate the process of even exporting the cannabis oil to Canada for testing and review. This primary step has given hope to the companies to develop new ideas and approach for generating cannabis-based businesses. Clever Leaves is the first company to attain the permission from the government to submit cannabis oil samples to Canada and it will be a success for the Colombian administration to get the approval from the company for getting the best quality medical cannabis.